Management of the patient with coagulation disorders.
Understanding normal haemostasis and the pathophysiology of its disorders is essential for providing optimal care and ensuring judicious usage of blood products, as is keeping abreast of novel therapeutic modalities in a rapidly evolving field. The growing availability of synthetic coagulation factors has (at least in the western hemisphere) helped to reduce morbidity and therapeutic complications, while expanding the indications and usage of these agents. Promising advances in gene therapy may indeed introduce a sea change in the next decade or two.
Govindaswamy
Sunitha
S
Department of Anaesthesia, Papworth Hospital, Cambridge, UK.
Chandler
Jim
J
Latimer
Ray
R
Vuylsteke
Alain
A